安徽建工(600502.SH):聯合體中標重慶榮昌至四川自貢高速公路(重慶段)特許經營者項目
格隆匯7月29日丨安徽建工(600502.SH)公佈,近日,本公司及所屬子公司收到項目中標通知書。項目名稱:重慶榮昌至四川自貢高速公路(重慶段)特許經營者,中標人:安徽建工集團股份有限公司(牽頭人)、安徽建工集團投資發展有限公司、安徽建工建設投資集團有限公司、安徽建工公路橋樑建設集團有限公司、安徽建工智能製造集團有限公司、安徽精睿築城建設有限公司聯合體。該項目位於重慶市榮昌區,項目內容主要包括本項目的投資、融資、建設、運營、維護及移交等。本項目採用政府和社會資本合作特許經營模式實施,實施方式爲BOT,估算總投資爲36.14億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.